<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01958684</url>
  </required_header>
  <id_info>
    <org_study_id>16954</org_study_id>
    <secondary_id>MA1310CN</secondary_id>
    <nct_id>NCT01958684</nct_id>
  </id_info>
  <brief_title>Bleeding Pattern Difference Between Levonorgestrel Intrauterine System (LNG-IUS) and Copper Intrauterine Devices (IUDs) Immediately Inserted After Abortion</brief_title>
  <acronym>POST</acronym>
  <official_title>A Non-interventional Study to Observe the Bleeding Pattern of LNG-IUS Inserted Immediately After Surgical Abortion Compared With Copper IUD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bayer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To observe the bleeding patterns of post-abortion immediate insertion of IUS compared to
      Cu-IUD over the first 6 months.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The number of bleeding/spotting days assessed over the second 90-day reference period after induced abortion</measure>
    <time_frame>Months 4 to 6</time_frame>
    <description>The 90-day reference period is recommended by the WHO. Day 1 is defined as the insertion day.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Menstrual bleeding intensity</measure>
    <time_frame>up to 6 months</time_frame>
    <description>It will be captured by patient dairy and measured by subjective scale as below.
No bleeding
Light bleeding
Normal bleeding
Heavy bleeding
Very heavy bleeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abortion related bleeding days</measure>
    <time_frame>up to 1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to the first menstrual bleeding following abortion</measure>
    <time_frame>up to 2 months</time_frame>
    <description>This data will be calculated by days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants continuation rates of Mirena and Cu-IUD</measure>
    <time_frame>up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reasons for discontinuation of Mirena and Cu-IUD</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>It will be calculated by percentage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants satisfaction rates of Mirena and Cu-IUD</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>It will be captured by satisfaction scale as below.
Very satisfied
Rather satisfied
neither satisfied nor dissatisfied
Rather unsatisfied
Very unsatisfied</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants with adverse events</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>Adverse events included: Pelvic inflammatory disease, Expulsion and Others.)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">512</enrollment>
  <condition>Contraception</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>The MIRENA intrauterine delivery system (initial release rate: 20 Î¼g LNG /24 h)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>Copper IUDs with different shape and with or without drugs</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levonorgestrel IUS (Mirena, BAY86-5028)</intervention_name>
    <description>LNG-IUS once inserted will be effective for 5 years.</description>
    <arm_group_label>Group 1</arm_group_label>
    <other_name>Mirena Group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Copper-IUD</intervention_name>
    <description>Copper-IUD once inserted will be effective for more than 10 years.</description>
    <arm_group_label>Group 2</arm_group_label>
    <other_name>Cu-IUD Group</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All subjects should go through the surgical abortion should meet both inclusion and
        exclusion criteria. And they are willing to sign an informed consent. And all recruitment
        should be conducted after the decision of treatment.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Reproductive women in good general health and requesting long-term contraception

          -  Applied the Cu-IUD or LNG-IUS immediately after first trimester surgical abortion

          -  History of regular cyclic menstrual periods

          -  Written ICF was obtained

        Exclusion Criteria:

          -  Suspected septic abortion and incomplete abortion, as well as missed abortion

          -  The contraindications and warnings of the respective Summary of Product
             Characteristics of Mirena or prescribing information of Cu-IUDs must be followed
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bayer Study Director</last_name>
    <role>Study Director</role>
    <affiliation>Bayer</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Many Locations</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm</url>
    <description>Click here and search for drug information provided by the FDA.</description>
  </link>
  <link>
    <url>http://www.fda.gov/medwatch/safety.htm</url>
    <description>Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.</description>
  </link>
  <link>
    <url>http://pharma.bayer.com/en/research-and-development/clinical-trials/trial-finder/index.php</url>
    <description>Click here and search for websynopsis results based on ICH E3 format provided by Bayer.</description>
  </link>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2013</study_first_submitted>
  <study_first_submitted_qc>October 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 9, 2013</study_first_posted>
  <last_update_submitted>October 15, 2015</last_update_submitted>
  <last_update_submitted_qc>October 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bleeding pattern</keyword>
  <keyword>LNG-IUS</keyword>
  <keyword>Cu-IUD</keyword>
  <keyword>postabortion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levonorgestrel</mesh_term>
    <mesh_term>Copper</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

